H B Fuller (FUL) Stock News

Moody's assigned a Ba3 rating to H.B. Fuller's new senior unsecured notes. Ba3 is a non-investment grade rating, indicating speculative credit quality.

H.B. Fuller plans to use proceeds from a financing to fund its acquisition of Advanced Medical Solutions Group. No additional details were immediately available.

H.B. Fuller (FUL) appointed R. Jeffrey Bailly to its board, effective immediately. Bailly, former CEO of UFP Technologies, led that company through 20+ acquisitions and a 20-fold revenue increase. He adds medical-technology expertise as H.B. Fuller pursues >20% adjusted EBITDA margin. Ruth Kimmelshue steps down after nine years.

H.B. Fuller Q3 Revenue Misses Estimate, Adjusted EPS Beats; Record EBITDA Margin, Guidance Raised.

H.B. Fuller reported fiscal Q3 net revenue of $938 million, up 5.2% year-on-year, with organic revenue up 4.4%. Adjusted EBITDA rose 9% to $187 million, with margin improving to 19.9%. Adjusted EPS was $1.52, up 21% year-on-year. The company updated its FY26 outlook: adjusted EBITDA now expected between $655-$670 million and adjusted EPS between $4.70-$4.85. Management cited pricing execution and restructuring savings driving margin expansion, while noting ongoing Middle East disruption impacting inventory strategy.